Averrhoa carambola L. fruit polyphenols ameliorate hyperlipidemia, hepatic steatosis, and hyperglycemia by modulating lipid and glucose metabolism in mice with obesity

Abstract

AbstractBACKGROUNDHyperlipidemia, hepatic steatosis, and hyperglycemia are common metabolic complications of obesity. The objective of the present study is to investigate the in vivo protective effect of Averrhoa carambola L. fruit polyphenols (ACFP) on hyperlipidemia, hepatic steatosis, and hyperglycemia in mice with high‐fat diet (HFD)‐induced obesity and elucidate the mechanisms of action underlying the beneficial effects of ACFP. Thirty‐six specific pathogen‐free male C57BL/6J mice (4 weeks old, weighing 17.1–19.9 g) were randomly divided into three groups and fed with a low‐fat diet (LFD, 10% fat energy), HFD (45% fat energy), or HFD supplemented with ACFP by intragastric administration for 14 weeks. Obesity‐related biochemical indexes and hepatic gene expression levels were determined. The statistical analyses were conducted using one‐way analysis of variance (ANOVA) followed by Duncan's multiple range test.RESULTSThe results showed that the body weight gain, serum triglycerides, total cholesterol, glucose, insulin resistance index, and steatosis grade in the ACFP group decreased by 29.57%, 26.25%, 27.4%, 19.6%, 40.32%, and 40%, respectively, compared to the HFD group. Gene expression analysis indicated that ACFP treatment improved the gene expression profiles involved in lipid and glucose metabolism compared to the HFD group.CONCLUSIONACFP protected from HFD‐induced obesity and obesity‐associated hyperlipidemia, hepatic steatosis, and hyperglycemia by improving lipid and glucose metabolism in mice. © 2023 Society of Chemical Industry.